live attenuated
Showing 26 - 50 of 3,321
Varicella Trial in Kaifeng (Investigational live attenuated varicella vaccine)
Completed
- Varicella
- Investigational live attenuated varicella vaccine
-
Kaifeng, Henan, ChinaXiangfu County Center for Disease Control and Prevention
Dec 8, 2021
Varicella Trial in Shangqiu (Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd,
Recruiting
- Varicella
- Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd
- +2 more
-
Shangqiu, Henan, ChinaYucheng Center for Disease Control and Prevention
Oct 14, 2021
Influenza Prevention Trial in Shijiazhuang Shi (Live Attenuated Influenza Vaccine, Live Attenuated Influenza Vaccine )
Recruiting
- Influenza Prevention
- Live Attenuated Influenza Vaccine
- Live Attenuated Influenza Vaccine placebo
-
Shijiazhuang Shi, Hebei, ChinaHebei Provincial Center for Disease Control and Prevention
Sep 23, 2021
Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral
Not yet recruiting
- Poliomyelitis
- Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
- Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
-
Panama City, Panama
- +3 more
Dec 14, 2022
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
Dengue Trial in Bangkok Noi (rDEN2?30-7169)
Not yet recruiting
- Dengue
- rDEN2Δ30-7169
-
Bangkok Noi, Bangkok, ThailandSiriraj Hospital
Jul 25, 2022
Influenza, Vaccine Virus Shedding Trial in London (Live attenuated influenza vaccine, Vehicle control)
Completed
- Influenza
- Vaccine Virus Shedding
- Live attenuated influenza vaccine
- Vehicle control
-
London, United KingdomImperial Clinical Respiratory Research Unit
Nov 1, 2021
Chikungunya Trial in São José Do Rio Preto (Active, Placebo)
Recruiting
- Chikungunya
- Active
- Placebo
-
São José Do Rio Preto, São Paulo, BrazilFaculdade de Medicina de São José do Rio Preto - FAMERP
Feb 22, 2022
Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553 full dose
- +2 more
- (no location specified)
Oct 24, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Cholera, Cholera Vaccine Toxicity Trial in Boston (PanChol)
Recruiting
- Cholera
- Cholera Vaccine Toxicity
- PanChol
-
Boston, MassachusettsBrigham and Women's Hospital Vaccine Unit
Dec 11, 2022
Childhood Cancer, Multiple Diseases Trial in New York (Immunization Schedule patients <7 years., Immunization Schedule patients
Active, not recruiting
- Childhood Cancer
- Multiple Diseases
- Immunization Schedule patients <7 years.
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center 1275 York Avenue
Aug 9, 2022
Herpes Zoster Trial in Nanjing, Hanzhou (live attenuated zoster vaccine, )
Completed
- Herpes Zoster
- live attenuated zoster vaccine
- placebo
-
Nanjing, Jiangsu, China
- +1 more
Dec 6, 2021
Ebola Virus Disease Trial in Baltimore (HPIV3/?HNF/EbovZ GP vaccine, Placebo)
Suspended
- Ebola Virus Disease
- HPIV3/ΔHNF/EbovZ GP vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Mar 2, 2022
Dengue Trial in Dhaka (TV005, rDEN2?30-7169 biotechnological synthetic attenuated virus strain)
Recruiting
- Dengue
- TV005
- rDEN2Δ30-7169 biotechnological synthetic attenuated virus strain
-
Dhaka, BangladeshIcddr,B
Feb 8, 2022
Influenza, Human Trial in Gentofte, Copenhagen, Hillerød (Vaxigripetra, Flumist)
Not yet recruiting
- Influenza, Human
- Vaxigripetra
- Flumist
-
Gentofte, Copenhagen, Denmark
- +5 more
Jul 4, 2023
Vaccine Response Trial in Atlanta, Decatur (Live Attenuated Yellow Fever 17D Vaccine, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Live Attenuated Yellow Fever 17D Vaccine
- Quadrivalent seasonal influenza vaccine
-
Atlanta, Georgia
- +2 more
Mar 25, 2023
Influenza Trial in Stanford (2008-2009 FluMist LAIV (Intranasal))
Terminated
- Influenza
- 2008-2009 FluMist LAIV (Intranasal)
-
Stanford, CaliforniaStanford University School of Medicine
Sep 21, 2021
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in United States (Live, attenuated, recombinant dengue serotypes 1, 2, 3,
Completed
- Dengue
- +3 more
- Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
- Yellow Fever
-
Alabaster, Alabama
- +6 more
Mar 15, 2022
Immunisation, Shigella Infection Trial in Cincinnati (Placebo, Shigella sonnei strain 53G, WRSs2)
Recruiting
- Immunisation
- Shigella Infection
- Placebo
- +2 more
-
Decatur, Georgia
- +1 more
Feb 2, 2023
Chikungunya Virus Infection Trial in San Juan (V184, Placebo)
Completed
- Chikungunya Virus Infection
- V184
- Placebo
-
San Juan, Puerto RicoSan Juan Hospital, Research Unit
Sep 6, 2022
Long-term Immunogenicity ofLive Herpes Zoster Vaccine in
Recruiting
- Lupus Erythematosus
- Immunogenicity
-
Hong Kong, ChinaDepartment of Medicine, Tuen Mun Hospital
Dec 18, 2021
Rotavirus Infections, Rotavirus Vaccines Trial in Perm (The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried),
Completed
- Rotavirus Infections
- Rotavirus Vaccines
- The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried)
- Placebo
-
Perm, Russian FederationPerm State Medical University named after Academician E.A. Wagne
Aug 31, 2021
Dengue Disease, Dengue Virus Trial (V181 High-Potency Level, V181 Mid-Potency Level, V181 Low-Potency Level)
Not yet recruiting
- Dengue Disease
- Dengue Virus
- V181 High-Potency Level
- +3 more
- (no location specified)
Aug 17, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022